{
    "clinical_study": {
        "@rank": "43603", 
        "acronym": "COP-AF Pilot", 
        "arm_group": [
            {
                "arm_group_label": "Active Colchicine", 
                "arm_group_type": "Experimental", 
                "description": "On the day of surgery, the intervention group will receive 2 doses of colchicine 0.6 mg orally.  The first dose will be administered within 4 hours before surgery.  The second dose will be given between 6:00PM and 11:59PM after surgery.  All patients will receive colchicine 0.6 mg or placebo twice daily orally for 10 days."
            }, 
            {
                "arm_group_label": "Placebo Colchicine", 
                "arm_group_type": "Placebo Comparator", 
                "description": "On the day of surgery, the intervention group will receive 2 doses of colchicine placebo 0.6 mg orally.  The first dose will be administered within 4 hours before surgery.  The second dose will be given between 6:00PM and 11:59PM after surgery.  All patients will receive colchicine 0.6 mg or placebo twice daily orally for 10 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this pilot study is to determine the feasibility of comparing colchicine to\n      placebo for the prevention of new onset atrial fibrillation in patients undergoing general\n      thoracic surgery and establish the foundation for a large, multi-centre, clinical trial."
        }, 
        "brief_title": "Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Atrial Fibrillation", 
            "Thoracic Surgery"
        ], 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients \u226555 years of age undergoing intra-thoracic surgery for a resection of\n             tumor in lung.\n\n        Exclusion Criteria:\n\n          -  In AF prior to surgery*,\n\n          -  Undergoing minor thoracic interventions/ procedures (i.e., chest tube insertion,\n             needle pleural/lung biopsies, or minor chest-wall surgeries), or\n\n          -  With contraindications to colchicine (i.e., allergy, or myelodysplastic disorders or\n             estimated glomerular filtration rate [e-GFR] <30 mL/min/1.73m)\n\n               -  Clarification: Patients with history of AF who are in sinus rhythm during\n                  enrollment will be eligible for recruitment. Patients who have no history of AF\n                  and are found to be in AF at the time of enrollment will not be eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985425", 
            "org_study_id": "COP-AF Pilot"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active Colchicine", 
                "intervention_name": "Colchicine", 
                "intervention_type": "Drug", 
                "other_name": "Brand names: PMS Colchicine, Colchicine TAB 0.6 mg"
            }, 
            {
                "arm_group_label": "Placebo Colchicine", 
                "intervention_name": "Colchicine Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Colchicine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2014", 
        "location": [
            {
                "contact": {
                    "email": "ssrinathan@exchange.hsc.mb.ca", 
                    "last_name": "Sadeesh Srinathan, MD", 
                    "phone": "(204) 787-3791"
                }, 
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3A 1R9"
                    }, 
                    "name": "University of Manitoba Health Sciences Centre"
                }, 
                "investigator": {
                    "last_name": "Sadeesh Srinathan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "nearyj@mcmaster.ca", 
                    "last_name": "John Neary, MD", 
                    "phone": "905-525-9140", 
                    "phone_ext": "37388"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8N 4A6"
                    }, 
                    "name": "St. Joseph Healthcare, St. Joseph Hospital"
                }, 
                "investigator": {
                    "last_name": "John Neary, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study.", 
        "overall_contact": {
            "email": "shirley.pettit@phri.ca", 
            "last_name": "Shirley Pettit", 
            "phone": "905-527-4322", 
            "phone_ext": "40526"
        }, 
        "overall_official": {
            "affiliation": "McMaster University", 
            "last_name": "PJ Devereaux, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "New atrial fibrillation that results in angina, congestive heart failure, symptomatic hypotension, or that requires treatment with a rate controlling drug, antiarrhythmic drug, or electrical cardioversion, or that lasts for longer than 30 seconds.", 
            "measure": "Clinically Significant Atrial Fibrillation", 
            "safety_issue": "No", 
            "time_frame": "Post-operative Day 1 until Postoperative Day 30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985425"
        }, 
        "responsible_party": {
            "investigator_affiliation": "McMaster University", 
            "investigator_full_name": "Philip Devereaux", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }, 
            {
                "description": "Replacement of the consistent P waves on 12-lead ECG, or documented telemetry tracing, by saw-tooth flutter waves.", 
                "measure": "New onset atrial flutter", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }, 
            {
                "description": "Requires one of the following criteria:\nA) Elevated troponin or CK-MB measurement with one or more of the following defining features:\nIschemic signs or symptoms (i.e., chest, arm, neck, or jaw discomfort; shortness of breath, pulmonary edema);\nDevelopment of pathologic Q waves present in any two contiguous leads that are >30 milliseconds;\nElectrocardiogram (ECG) changes indicative of ischemia (i.e., ST segment elevation [>2 mm in leads V1, V2, or V3 OR >1 mm in the other leads], ST segment depression [>1 mm], OR symmetric inversion of T waves >1 mm) in at least two contiguous leads;\nNew LBBB; or v. new or presumed new cardiac wall motion abnormality on echocardiography or new or presumed new fixed defect on radionuclide imaging;\nB) Elevated troponin measurement after surgery with no alternative explanation (e.g., pulmonary embolism, sepsis) to myocardial injury", 
                "measure": "Myocardial Injury After Non-Cardiac Surgery (MINS)", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }, 
            {
                "description": "New focal neurological deficit thought to be vascular in origin with signs and symptoms lasting more than 24 hours and cerebral imaging consistent with acute stroke.", 
                "measure": "Stroke", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }, 
            {
                "description": "New focal neurological deficit thought to be vascular in origin with signs and symptoms lasting less than 24 hours.", 
                "measure": "Transient Ischemic Attack (TIA)", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }, 
            {
                "measure": "Post-operative infection", 
                "safety_issue": "No", 
                "time_frame": "Post-operative Day 1 until Postoperative Day 30"
            }
        ], 
        "source": "McMaster University", 
        "sponsors": {
            "collaborator": {
                "agency": "Canadian Institutes of Health Research  (CIHR)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "McMaster University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}